This supports the observations reported by other groups that IDH1/2 mutations in GBM are associated with a fascinating link to 2-hydroxyglutarate (2-HG) accumulation representing an altered metabolite profile, which may have broad implications for both cancer epigenetics and clinical management of disease [28]. Here, IDH1 is linked to glioblastoma.